RhumbLine Advisers Portfolio holdings
AUM $117B
1-Year Return
24.59%
This Quarter Return
-3.41%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,770
Reduced
217
Closed
40
Top Buys
| 1 |
Microsoft
MSFT
|
+$129M |
| 2 |
Tesla
TSLA
|
+$66.8M |
| 3 |
Apple
AAPL
|
+$66.7M |
| 4 |
Amazon
AMZN
|
+$58.1M |
| 5 |
Procter & Gamble
PG
|
+$49.7M |
Top Sells
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$19M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
2626
Kalaris Therapeutics, Inc. Common Stock
KLRS
$93.7M
| $376K | ﹤0.01% |
2,074
+186
| +10% | +$33.7K |
|
2627
Generation Bio
GBIO
$40.1M
| $375K | ﹤0.01% |
7,066
+588
| +9% | +$31.2K |
|
2628
Vera Therapeutics
VERA
$1.57B
| $375K | ﹤0.01% |
17,600
+1,328
| +8% | +$28.3K |
|
2629
Hippo Holdings
HIPO
$931M
| $374K | ﹤0.01% |
20,179
+5,746
| +40% | +$106K |
|
2630
Orrstown Financial Services
ORRF
$676M
| $374K | ﹤0.01% |
15,626
+862
| +6% | +$20.6K |
|
2631
Utah Medical Products
UTMD
$200M
| $374K | ﹤0.01% |
4,389
+275
| +7% | +$23.4K |
|
|
WE
2632
DELISTED
WeWork Inc.
WE
| $372K | ﹤0.01% |
3,506
+880
| +34% | +$93.4K |
|
|
AFCG
2633
AFC Gamma
AFCG
$99.2M
| $370K | ﹤0.01% |
35,292
+2,016
| +6% | +$21.1K |
|
|
MCBC
2634
DELISTED
Macatawa Bank Corp
MCBC
| $370K | ﹤0.01% |
40,006
+2,318
| +6% | +$21.4K |
|
2635
ACNB Corp
ACNB
$472M
| $367K | ﹤0.01% |
12,232
+676
| +6% | +$20.3K |
|
2636
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $366K | ﹤0.01% |
13,016
+856
| +7% | +$24.1K |
|
2637
4D Molecular Therapeutics
FDMT
$311M
| $365K | ﹤0.01% |
45,373
+3,788
| +9% | +$30.5K |
|
2638
Quantum-Si Incorporated
QSI
$255M
| $365K | ﹤0.01% |
132,596
+7,503
| +6% | +$20.7K |
|
2639
Hyster-Yale Materials Handling
HY
$636M
| $364K | ﹤0.01% |
16,931
+967
| +6% | +$20.8K |
|
|
ATH.PRA
2640
Athene Holding Ltd Series A
ATH.PRA
$875M
| $363K | ﹤0.01% |
14,875
| – | – |
|
2641
Liberty Latin America Class A
LILA
$1.55B
| $363K | ﹤0.01% |
58,698
+3,917
| +7% | +$24.2K |
|
2642
PLAYSTUDIOS Inc
MYPS
$120M
| $363K | ﹤0.01% |
103,957
+6,403
| +7% | +$22.4K |
|
2643
Lifecore Biomedical
LFCR
$294M
| $362K | ﹤0.01% |
40,701
+2,820
| +7% | +$25.1K |
|
2644
BCB Bancorp
BCBP
$149M
| $360K | ﹤0.01% |
21,408
+1,096
| +5% | +$18.4K |
|
2645
BioXcel Therapeutics
BTAI
$46.4M
| $359K | ﹤0.01% |
1,897
+115
| +6% | +$21.8K |
|
2646
Rackspace Technology
RXT
$345M
| $359K | ﹤0.01% |
87,977
+5,674
| +7% | +$23.2K |
|
|
AFMD
2647
DELISTED
Affimed
AFMD
| $358K | ﹤0.01% |
17,396
+949
| +6% | +$19.5K |
|
2648
Northeast Bank
NBN
$932M
| $357K | ﹤0.01% |
9,734
+543
| +6% | +$19.9K |
|
2649
Upland Software
UPLD
$71.4M
| $357K | ﹤0.01% |
43,880
+2,415
| +6% | +$19.6K |
|
|
TPC
2650
Tutor Perini Corporation
TPC
$3.37B
| $356K | ﹤0.01% |
64,513
+4,042
| +7% | +$22.3K |
|